SHAREHOLDER ALERT: Levi & Korsinsky Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Trius Therapeutics, Inc. in Connection with the Sale of Company to Cubist Pharmaceuticals, Inc.